Skip to main content
. 2018 Nov 29;126(1):246–254. doi: 10.1152/japplphysiol.00804.2018

Table 4.

Plasma nitrite [NO2] and nitrate [NO3] concentrations

Baseline Time 0, min Post Time 2, min Post Time 4, min Post Time 15, min Post Time 30, min Post Time 45, min Post
[NO2], nmol/l*#
    Placebo
        Pre 87.3 ± 7.6 63.5 ± 4.2 70.9 ± 3.4 68.3 ± 4.8 72.8 ± 10.8 69.0 ± 5.7 71.0 ± 7.4
        Post 104.2 ± 13.5 91.3 ± 9.7 86.2 ± 9.1 83.8 ± 11.3 88.7 ± 7.6 82.3 ± 6.5 76.5 ± 6.9
    MC
        Pre 82.1 ± 10.0 80.7 ± 11.1 74.2 ± 11.3 71.9 ± 10.1 68.2 ± 14.9 64.2 ± 11.8 66.8 ± 10.1
        Post 83.2 ± 10.5 65.6 ± 7.3 77.7 ± 8.6 70.2 ± 6.4 81.1 ± 7.3 74.2 ± 9.4 77.0 ± 10.7
[NO3], µmol/l*
    Placebo
        Pre 32.8 ± 3.9 29.7 ± 3.6 28.6 ± 3.5 28.7 ± 3.3 27.7 ± 2.9 27.9 ± 2.9 27.2 ± 3.0
        Post 27.3 ± 2.6 25.7 ± 3.0 26.8 ± 3.3 25.9 ± 2.4 25.7 ± 2.7 24.4 ± 2.8 25.8 ± 2.7
    MC
        Pre 27.6 ± 4.9 24.8 ± 4.4 26.2 ± 4.7 25.8 ± 4.8 25.6 ± 4.6 25.0 ± 4.5 24.7 ± 4.1
        Post 29.5 ± 5.2 28.2 ± 4.9 29.3 ± 4.9 27.9 ± 4.9 26.8 ± 4.7 26.6 ± 4.4 26.3 ± 4.4

Values are expressed as means ± SE. Plasma [NO2] and [NO3] measured 15 min before 20-min occlusion (baseline), and immediately, 2, 4, 15, 30, and 45 min after reperfusion, before, and after placebo or Montmorency cherry (MC) supplementation.

*

Main effect of time P < 0.001.

#

Three-way interaction effect.